Purchase Order 75N93024P00358

Award Date 2/19/24
Potential Completion Date 5/19/24
Potential Value $15K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Becton, Dickinson and Company (BD), through its BD Biosciences division, has been awarded an 11-month firm fixed price purchase order valued at $200,435.84 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for various equipment and laser services to be performed at the agency's facility in Bethesda, Maryland. No set-aside designation was applied to this solicitation. As the prime contractor, BD will leverage its expertise providing...
Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Becton, Dickinson And Company (BD) for maintenance services on BD Biosciences equipment, including the FACSymphony A5 and associated lasers. The $216,000 contract has a period of performance from November 7, 2022 to November 6, 2026 and does not utilize a small business set-aside. BD, a global medical technology company,...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
Becton, Dickinson and Company, doing business as BD, has been awarded a purchase order contract valued at approximately $13,924.50 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under the terms of the contract, BD will provide BD Antibodies (AMBIS #2187100) to support NIH/NIAID's research efforts related to allergies and infectious diseases. Place of performance will be BD's facilities in Franklin Lakes, New Jersey, with work expected to be...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to Becton, Dickinson and Company (BD) for the supply of one FACSymphony A5 SORP & Fortessa System cell analyzer, valued at $574,988.05. The contract has no set-aside designation. BD is a global medical technology company that provides a wide range of equipment, reagents, and services to support biomedical research...
Becton, Dickinson and Company (BD Biosciences division) has been awarded a firm fixed price purchase order totaling $17,668.80 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for annual service of BD Biosciences' FACSCelesta flow cytometry system located in San Jose, California, with performance through March 1, 2025. No set-aside designation was used for this procurement. BD Biosciences will provide maintenance and support for the...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $73,666.80 firm fixed price purchase order to Becton, Dickinson and Company (BD) for a service contract to provide a FACSymphony S6 cell sorter and 5 various lasers. This contract does not have a set-aside designation. BD is a global medical technology company that develops, manufactures, and sells medical supplies, instruments, laboratory equipment, and diagnostic products. The company has extensive experience...
This is a $141,833.76 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company's BD Biosciences division. The contract is for an annual service agreement to provide BD equipment in Rockville, Maryland. The award does not have a set-aside designation. Becton, Dickinson and Company is a global medical technology company that develops, manufactures, and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), a leading manufacturer of medical devices, instruments, and reagents. The $33,778.80 contract is for a maintenance agreement on a FACS Celesta and Sampler, healthcare equipment used in biomedical research. This order was not set aside for any specific business type. As a prime contractor,...

Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order valued at fifteen thousand dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. This award is for pre-contract inspection services to support the BD FACSymphony A5 cell analyzer, to be performed in Bethesda, Maryland. No set-aside designation was used for this procurement. BD Biosciences, a division of BD, will provide the required inspection services leveraging its expertise in specialized biomedical equipment and consumables. This purchase order allows the funding agency to obtain pre-implementation validation of a key cell analysis instrument to enable biomedical research and clinical programs conducted by the National Institute of Allergy and Infectious Diseases.

Generated 2/18/24, 12:27 AM